Abstract
The development of ascites in patients with cirrhosis is common and represents altered function of the regulatory mechanisms governing extracellular fluid. Ascites is a major burden for patients suffering from chronic liver disease and imposes a significant degree of morbidity and mortality. This chapter will focus on the pathophysiology leading to the development of ascites, the diagnosis and evaluation of ascites, common complications encountered by the clinician, and treatment strategies to guide medical decision making to aid in the long-term management of patients with ascites. Lastly, areas of active research and future diagnostic and therapeutic techniques will be discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moore KP et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38(1):258–66.
Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med. 1992;117:215–20.
Cattau E, Benjamin S, Knuff T, et al. The accuracy of the physical exam in the diagnosis of suspected ascites. JAMA. 1982;247:1164–6.
Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57(4):1651–3.
Runyon BA. Paracentesis of ascitic fluid: a safe procedure. Arch Intern Med. 1986;146:2259–61.
Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 1988;8:1104–9.
Runyon BA, Antillon MR, Akriviadis EA, et al. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol. 1990;8:2811–2.
Runyon BA. Cardiac ascites: a characterization. J Clin Gastroenterol. 1988;10:410–2.
Akriviadis EA, Runyon BA. The value of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 1990;98:127–33.
Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology. 1988;95:1351–5.
Hillebrand DJ, Runyon BA, Yasmineh WG, et al. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology. 1996;24:1408–12.
Pereira G, Guevara M, Fagundes C, Solá E, Rodríguez E, Fernández J, et al. Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study. J Hepatol. 2012;56:1040–6.
Belghiti J, Rueff B, Fekete F. Umbilical hernia in cirrhotic-patients with ascites-prevalence, course, and management. Gastroenterology. 1983;84:1363A.
Runyon BA, Antillon MR, Montano AA. Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and serum complement. Gastroenterology. 1989;97(1):158–62.
Chalasani N et al. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol. 2001;12(5):1010–6.
Stanley MM et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med. 1989;321(24):1632–8.
Singh V et al. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study. J Hepatol. 2012;56(2):348–54.
Smith GS, Barnard GF. Massive volume paracentesis (up to 41 liters) for the outpatient management of ascites. J Clin Gastroenterol. 1997;25(1):402–3.
Ginès P et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988;94:1493–502.
Bernardi M et al. Albumin infusion in patients undergoing large‐volume paracentesis: a meta‐analysis of randomized trials. Hepatology. 2012;55(4):1172–81.
Peltekian KM et al. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol. 1997;92(3):394–9.
Saab S, et al. TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane Database Syst Rev 2006;(4):CD004889.
D’Amico G et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. Gastroenterology. 2005;129(4):1282–93.
Angermayr B et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE‐covered stentgrafts versus bare stents. Hepatology. 2003;38(4):1043–50.
Bureau C et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126(2):469–75.
Montgomery A et al. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol. 2005;28(3):307–12.
Romanelli RG et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. World J Gastroenterol. 2006;12(9):1403–7.
Krag A et al. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome. Hepatology. 2007;46(6):1863–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Schiro, A.J. (2017). Ascites. In: Saeian, K., Shaker, R. (eds) Liver Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-30103-7_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-30103-7_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30101-3
Online ISBN: 978-3-319-30103-7
eBook Packages: MedicineMedicine (R0)